Spironolactone is associated with reduced mitotane levels in adrenocortical carcinoma patients

DSpace Repository

Spironolactone is associated with reduced mitotane levels in adrenocortical carcinoma patients

Author: Haberbosch, Linus; Maurer, Lukas; Sandforth, Arvid; Wernicke, Charlotte; Spranger, Joachim; Mai, Knut; von Schwartzenberg, Reiner Jumpertz
Tübinger Autor(en):
Sandforth, Arvid
Jumpertz-von Schwartzenberg, Reiner
Published in: Endocrine - Related Cancer (2022), Bd. 29, H. 3, S. 121-128
Verlagsangabe: Bioscientifica Ltd
Language: English
Full text: http://dx.doi.org/10.1530/ERC-21-0202
ISSN: 1351-0088
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)